Fractional erbium laser versus fractional erbium laser with topical autologous platelet-rich plasma in the treatment of acne scars: A split-face comparison clinical trial

Phase 3

• Conditions: Acne scar; Fractional erbium laser; Autologous platelet-rich plasma; acne scars; acne

• Registration Number: TCTR20231115004
• Lead Sponsor: the Institute of Dermatology, Bangkok, Thailand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-11-15
• Study Completion: 2023-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Male or female
2. Age 18 - 40 years
3. Good health
4. Skin fitzpatrick skin type 3 or 4
5. Atrophic acne scars on face

Exclusion Criteria

1. The patient prone to be keloid, severe acne, Herpes infection, HIV patient, Hepatitis b virus infection
2. Hypertrophic acne scar and keloidal acne scar on face
3. The pateint were taken isotretinoin in past 6 month periods
4. DM, Connective tissue disease.
5. The patient were treated with ablative or nonablative laser in past 12 months
6. Pregnancy or breastfeeding
7. The patient prone to be easily bleeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
improvement of acne scar 3 months quartile grading scale

Secondary Outcome Measures

Name	Time	Method
patient overall satisfaction 3 months quartile grading system